XERS Logo

Xeris Biopharma Holdings, Inc. (XERS) 

NASDAQ$5.03
Market Cap
$749.88M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
355 of 924
Rank in Industry
208 of 527

XERS Insider Trading Activity

XERS Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$30,5953100
Sells
$000

Related Transactions

Schmid John P.director3$30,5950$0$30,595

About Xeris Biopharma Holdings, Inc.

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's â€¦

Insider Activity of Xeris Biopharma Holdings, Inc.

Over the last 12 months, insiders at Xeris Biopharma Holdings, Inc. have bought $30,595 and sold $0 worth of Xeris Biopharma Holdings, Inc. stock.

On average, over the past 5 years, insiders at Xeris Biopharma Holdings, Inc. have bought $316,957 and sold $151,244 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Schmid John P. (director) — $30,595.

The last purchase of 4,515 shares for transaction amount of $10,147 was made by Schmid John P. (director) on 2024‑08‑12.

List of Insider Buy and Sell Transactions, Xeris Biopharma Holdings, Inc.

2024-08-12PurchaseSchmid John P.director
4,515
0.003%
$2.25$10,147+44.22%
2024-08-09PurchaseSchmid John P.director
4,285
0.0029%
$2.37$10,134+39.66%
2024-05-10PurchaseSchmid John P.director
5,400
0.004%
$1.91$10,314+68.18%
2024-03-14PurchaseSchmid John P.director
4,500
0.0032%
$2.16$9,720+32.63%
2023-11-27PurchaseSHERMAN JEFFREY Wdirector
5,400
0.004%
$1.87$10,098+32.07%
2023-11-20PurchasePieper StevenSee Remarks
28,000
0.0218%
$1.95$54,600+32.42%
2023-11-20PurchaseHALKUFF DAWNdirector
5,410
0.004%
$1.84$9,954+32.42%
2023-11-17PurchaseShannon John Patrick JrSee Remarks
30,769
0.0206%
$1.64$50,400+34.46%
2023-11-16PurchaseSchmid John P.director
6,500
0.0045%
$1.51$9,815+51.59%
2023-11-14PurchasePERSKY MARLAdirector
6,370
0.0047%
$1.58$10,058+52.24%
2023-08-09PurchaseEdick Paul RSee Remarks
10,000
0.0073%
$2.38$23,794-9.79%
2022-12-13PurchaseEdick Paul RSee Remarks
20,000
0.0152%
$1.45$29,000+34.75%
2022-05-12PurchaseEdick Paul RSee Remarks
100,000
0.0681%
$1.40$140,380+0.66%
2022-02-22SalePRESTRELSKI STEVENChief Scientific Officer
11,228
0.0085%
$2.42$27,158-32.35%
2021-11-15PurchaseEdick Paul RSee Remarks
20,000
0.0151%
$2.28$45,664-17.14%
2021-11-12PurchaseShannon John Patrick JrSee Remarks
60,000
0.0484%
$2.10$126,000-2.80%
2021-11-11PurchaseEdick Paul RSee Remarks
200,000
0.1644%
$2.08$415,7600.00%
2021-11-11PurchaseShannon John Patrick JrSee Remarks
40,000
0.033%
$2.09$83,5000.00%
2021-11-10PurchasePieper StevenSee Remarks
25,000
0.0216%
$2.00$49,918+9.47%
2021-04-12SalePRESTRELSKI STEVENChief Scientific Officer
10,000
0.0156%
$4.07$40,725-34.99%
Total: 58
*Gray background shows transactions not older than one year

Insider Historical Profitability

14.31%
Schmid John P.director
25200
0.0169%
$126,756.0050+42.11%
Redmile Group, LLC10 percent owner
3000642
2.0128%
$15.09M20<0.0001%
Edick Paul RSee Remarks
2288064
1.5348%
$11.51M100+1.38%
Palmetto Partners, Ltd.10 percent owner
2110061
1.4154%
$10.61M10<0.0001%
Shannon John Patrick JrSee Remarks
1408575
0.9448%
$7.09M60+19.99%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$3,596,906
112
13.42%
$635.29M
$36,510,315
95
8.95%
$617.34M
$7,929,017
58
21.56%
$788.11M
$97,176
41
42.84%
$782.59M
$94,912,877
34
-7.15%
$620.95M

XERS Institutional Investors: Active Positions

Increased Positions90+68.7%10M+16.26%
Decreased Positions45-34.35%9M-13.7%
New Positions32New3MNew
Sold Out Positions14Sold Out1MSold Out
Total Postitions176+34.35%65M+2.57%

XERS Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$52,158.007.03%10.82M+87,097+0.81%2024-12-31
Vanguard Group Inc$38,073.005.13%7.9M+133,738+1.72%2024-12-31
Geode Capital Management, Llc$16,154.002.18%3.35M+17,956+0.54%2024-12-31
State Street Corp$16,108.002.17%3.34M+137,156+4.28%2024-12-31
Rosalind Advisors, Inc.$14,966.002.02%3.1M00%2024-12-31
Morgan Stanley$13,870.001.87%2.88M+523,208+22.22%2024-12-31
Aigh Capital Management Llc$12,411.001.67%2.57M+389,192+17.81%2024-12-31
Renaissance Technologies Llc$10,116.001.36%2.1M+500,120+31.28%2024-12-31
Caxton Corp$9,713.001.31%2.02M-3M-60.59%2024-12-31
Millennium Management Llc$9,392.001.27%1.95M+502,853+34.78%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.